C
Cover 50 SpA
MIL:COV
Cover 50 SpA
MIL:COV
Price:
13.4
EUR
-0.74%
Market Closed
Market Cap:
€59m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cover 50 SpA
MIL:COV
|
IT |
|
Mackenzie Realty Capital Inc
OTC:MKZR
|
US |
|
Wee-Cig International Corp
OTC:WCIG
|
US |
|
Kyushu Electric Power Co Inc
TSE:9508
|
JP |
|
Xenetic Biosciences Inc
NASDAQ:XBIO
|
US |
|
Qingdao Vland Biotech INC
SSE:603739
|
CN |
|
T
|
Tri Viet Asset Management Corporation JSC
VN:TVC
|
VN |
|
G
|
Gogoro Inc
NASDAQ:GGR
|
TW |
|
R
|
Rex Trueform Group Ltd
JSE:RTO
|
ZA |
|
Lycopodium Ltd
ASX:LYL
|
AU |
Balance Sheet
Balance Sheet Decomposition
Cover 50 SpA
Cover 50 SpA
Balance Sheet Decomposition is not available for
Cover 50 SpA
Cover 50 SpA
Balance Sheet
Cover 50 SpA
Cover 50 SpA
Currency: EUR
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
12
|
12
|
9
|
|
| Cash |
12
|
12
|
9
|
|
| Cash Equivalents |
0
|
0
|
0
|
|
| Short-Term Investments |
8
|
11
|
14
|
|
| Total Receivables |
9
|
8
|
10
|
|
| Accounts Receivables |
7
|
8
|
9
|
|
| Other Receivables |
2
|
1
|
1
|
|
| Inventory |
8
|
8
|
9
|
|
| Other Current Assets |
1
|
1
|
1
|
|
| Total Current Assets |
37
|
39
|
43
|
|
| PP&E Net |
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
|
| Total Assets |
38
N/A
|
40
+5%
|
44
+11%
|
|
| Liabilities | ||||
| Accounts Payable |
4
|
4
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
1
|
|
| Other Current Liabilities |
1
|
1
|
3
|
|
| Total Current Liabilities |
6
|
7
|
9
|
|
| Long-Term Debt |
3
|
2
|
1
|
|
| Other Liabilities |
2
|
2
|
3
|
|
| Total Liabilities |
11
N/A
|
11
-4%
|
13
+21%
|
|
| Equity | ||||
| Common Stock |
4
|
4
|
4
|
|
| Retained Earnings |
15
|
18
|
20
|
|
| Additional Paid In Capital |
7
|
7
|
7
|
|
| Other Equity |
0
|
0
|
0
|
|
| Total Equity |
27
N/A
|
29
+9%
|
31
+7%
|
|
| Total Liabilities & Equity |
38
N/A
|
40
+5%
|
44
+11%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
4
|
4
|
4
|
|
Switch to:
Switch to:
See Also
Discover More
